{
    "clinical_study": {
        "@rank": "21680", 
        "arm_group": [
            {
                "arm_group_label": "Supplemental oxygen", 
                "arm_group_type": "Experimental", 
                "description": "Supplemental oxygen 3 liters/minute given via a nasal cannula for 16 hours a day"
            }, 
            {
                "arm_group_label": "Sham room air", 
                "arm_group_type": "Sham Comparator", 
                "description": "Room air given at a flow rate of 3 liters per minute for 16 hours a day"
            }
        ], 
        "brief_summary": {
            "textblock": "In this randomized-controlled, cross-over trial the investigators test the effect of\n      long-term oxygen therapy (> 16h/day) given for 5 weeks with a wash-out period between phases\n      of 2 weeks on exercise performance and quality of life and many physiological parameters in\n      patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension."
        }, 
        "brief_title": "Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension", 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Hypertension, Pulmonary"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n        - Adult patients with established diagnosis of pulmonary arterial or chronic\n        thromboembolic PH (class I and IV according to the latest WHO classification scheme of\n        Dana Point 2008) on optimized medical therapy and in stable condition for at least 4\n        weeks, who desaturate in the 6 minute walking test by =4% to values <92%.\n\n        Exclusion criteria:\n\n          -  Patients in unstable conditions requiring frequent therapeutic adaption\n\n          -  pregnant women\n\n          -  patients with pulmonary venous hypertension due to left heart diseases\n\n          -  patients with relevant concomitant lung disease and severe daytime hypoxemia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01884012", 
            "org_study_id": "KEK 2012-0538"
        }, 
        "intervention": {
            "arm_group_label": [
                "Supplemental oxygen", 
                "Sham room air"
            ], 
            "intervention_name": "long term oxygen therapy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 18, 2013", 
        "location": {
            "contact": {
                "email": "silvia.ulrich@usz.ch", 
                "last_name": "Silvia Ulrich, MD", 
                "phone": "++41442554362"
            }, 
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "state": "ZH", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich, Division of Pneumology"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "silvia.ulrich@usz.ch", 
            "last_name": "Silvia Ulrich Somaini, MD"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Zurich, Division of Pneumology", 
            "last_name": "Silvia Ulrich Somaini, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "6 minute walk distance according to ATS guidelines", 
                "measure": "6 minute walk test", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "description": "QoL assessed by the SF-36 questionnaire physical functioning scale", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01884012"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "measured by actigraphy", 
                "measure": "Daily activity", 
                "safety_issue": "No", 
                "time_frame": "5 week"
            }, 
            {
                "description": "Full echocardiographic assessment", 
                "measure": "hemodynamics by echocardiography", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "description": "short form of the medical outcome questionnaire [SF-36]", 
                "measure": "quality of life", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "description": "PaO2", 
                "measure": "arterial blood gas", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "description": "efficacy of oxygen treatment", 
                "measure": "operating hours of oxygen concentrator", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "description": "Ambulatory Sleep Study", 
                "measure": "mean nocturnal oxygen saturation", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "description": "STROOP-Test", 
                "measure": "tests of cognitive performance", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "description": "Minnesota living with heart failure questionnaire", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "description": "NT-proBNP", 
                "measure": "Venous blood", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }
        ], 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}